Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The proteasome subunit psmb1 is essential for craniofacial cartilage maturation and morphogenesis
Bess M. Miller, Wolfram Goessling
Bess M. Miller, Wolfram Goessling
View: Text | PDF
Research Article Development

The proteasome subunit psmb1 is essential for craniofacial cartilage maturation and morphogenesis

  • Text
  • PDF
Abstract

Craniofacial dysmorphisms are among the most common birth defects. Proteasome mutations frequently result in craniofacial dysmorphisms, including lower jaw malformations; however, the underlying mechanisms are unknown. Here, we used a zebrafish proteasome subunit β 1 (psmb1) mutant to define the cellular mechanisms underlying proteasome mutation-induced craniofacial dysmorphisms. psmb1 mutants exhibited a flattened ceratohyal and smaller Meckel’s and palatoquadrate cartilages. Ceratohyal flattening was a result of failed chondrocyte convergent extension, accompanied by reduced numbers of chondrocytes in the lower jaw due to defects in chondrocyte differentiation. Morphogenesis of craniofacial muscles and tendons was similarly perturbed. psmb1 mutants lacked the hyohyal muscles, and craniofacial tendons were shortened and disorganized. We additionally identified a critical period for proteasome function in craniofacial development, specifically during chondrocyte and muscle differentiation. psmb1 overexpression in sox10+ cells of mutant embryos rescued both cartilage and tendon phenotypes but induced only a partial rescue of the muscle phenotype, indicating that psmb1 was required in both tissue-autonomous and nonautonomous fashions during craniofacial development. Overall, our work demonstrates that psmb1 is required for craniofacial cartilage, tendon, and muscle differentiation and morphogenesis.

Authors

Bess M. Miller, Wolfram Goessling

×

Figure 2

Chondrocyte cell death and proliferation in psmb1 mutants.

Options: View larger image (or click on image) Download as PowerPoint
Chondrocyte cell death and proliferation in psmb1 mutants.
(A) Time-cour...
(A) Time-course study of apoptag TUNEL staining (green) and Sox9a staining (magenta) from 55–72 hpf. (B–E) Quantification of A demonstrates that cell death is not elevated in mutant chondrocytes until 72 hpf, at which point sox9a+TUNEL+ cells can be found (white arrowhead). 55 hpf: n = 10 (+/+), 16 (+/–), 6 (–/–). 60 hpf: n = 10 (+/+), 21 (+/–), 8 (–/–). 65 hpf: n = 6 (+/+), 6 (+/–), 6 (–/–). 72 hpf: n = 8 (+/+), 10 (+/–), 10 (–/–). (F) pH3 (magenta) antibody staining in sox10:kaede larvae (green) at 57 hpf, 65 hpf, and 72 hpf. (G–I) Quantification of C shows no proliferation of craniofacial chondrocytes across genotypes. 57 hpf: n = 6 (+/+), 10 (+/–), 6 (–/–). 65 hpf: n = 10 (+/+), 14 (+/–), 7 (–/–). 72 hpf: n = 7 (+/+), 11 (+/–), 9 (–/–). Scale bars: 50 μm. Data shown represent mean ± SD. Significance was calculated with 1-way ANOVA with Dunnett’s multiple comparisons test. *P < 0.05; ns, not significant.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts